ArticleThe Journal of international medical research2025
Occult hepatitis B virus infection and its demographic and clinical determinants among blood donors in Saudi Arabia: A retrospective cross-sectional study.
Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Implications of occult hepatitis B infection for blood donor management: a five-year evaluation from Western Saudi Arabia.BMC infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveOccult hepatitis B virus infection, characterized by the presence of hepatitis B virus DNA in the absence of detectable hepatitis B surface antigen, poses a significant risk to blood donation safety. This study aimed to determine the prevalence of occult hepatitis B virus infection and identify demographic and clinical predictors among blood donors in Saudi Arabia who were negative for hepatitis B surface antigen.MethodsA retrospective cross-sectional study was conducted using donor records to evaluate hepatitis B virus and other transfusion-transmissible infection markers. Demographic data were extracted, and multivariable logistic regression was performed to identify predictors of hepatitis B core antibody and hepatitis B virus DNA positivity.ResultsAmong the 49,502 donors negative for hepatitis B surface antigen, 27 had occult hepatitis B virus infection, representing a prevalence of 0.054%. Occult hepatitis B virus infection was more frequent among donors aged 31-40 and >51 years and was significantly associated with non-Saudi nationality, Middle Eastern and Asian origin, and syphilis coinfection. Syphilis was also significantly associated with prior hepatitis B virus exposure, as indicated by hepatitis B core antibody positivity. Notably, 5 of the 27 patients with occult hepatitis B virus infection (18.5%) were negative for hepatitis B core antibody, indicating that these cases would have been missed using serological screening alone.ConclusionThe prevalence of occult hepatitis B virus infection among blood donors in Saudi Arabia is low but clinically relevant. These findings underscore the limitations of serological screening alone and support the incorporation of nucleic acid testing to enhance transfusion safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.